Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Advanced Rare Tumours × tremelimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrent Squamous Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Colorectal Neoplasms 2 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignancies 1 Neoplasms 1 Lung Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Rare Tumours 1

Interventions

tremelimumab 1 temsirolimus 1 durvalumab 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02879162 2025-03-07

Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours

Canadian Cancer Trials Group

Phase 2 Completed

140 enrolled 9 charts

Advanced Rare Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡